Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (341-350 of 664) with videos related to

Pageof 67
Sort By:
Lung Cancer (Amsterdam, Netherlands)|December 7, 2007
Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancerChristian Peschel, Joerg T Hartmann, Alexander Schmittel, et al.
Human Pathology|November 10, 2009
Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancerMatthias Choschzick, Annette Lebeau, Andreas H Marx, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologieEray Goekkurt, Salah-Eddin Al-Batran, Jörg T Hartmann, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2007
Lectin histochemistry of metastatic adenocarcinomas of the lungIna Thöm, Olaf Schult-Kronefeld, Iris Burkholder, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 27, 2012
Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancerAnna Flammiger, Florian Bayer, Ana Cirugeda-Kühnert, et al.
Blood|February 13, 2008
Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315IArtur Gontarewicz, Stefan Balabanov, Gunhild Keller, et al.
Future Oncology (London, England)|September 9, 2020
Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of care in resectable head and neck squamous cell carcinomaHenrike B Zech, Nikolaus Moeckelmann, Arne Boettcher, et al.
Urologic Oncology|December 25, 2015
Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care--Registry data from an outcomes research project of the German Testicular Cancer Study GroupChristoph Seidel, Karin Oechsle, Anja Lorch, et al.
British Journal of Cancer|September 4, 2015
Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancerAlexander Stein, Djordje Atanackovic, Bert Hildebrandt, et al.
Cancers|April 12, 2022
Indirect Treatment Comparison of Larotrectinib versus Entrectinib in Treating Patients with TRK Gene Fusion CancersJesus Garcia-Foncillas, Carsten Bokemeyer, Antoine Italiano, et al.
Pageof 67

Showing results (341-350 of 664) with videos related to

Sort By:
Pageof 67
Lung Cancer (Amsterdam, Netherlands)|December 7, 2007
Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancerChristian Peschel, Joerg T Hartmann, Alexander Schmittel, et al.
Human Pathology|November 10, 2009
Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancerMatthias Choschzick, Annette Lebeau, Andreas H Marx, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologieEray Goekkurt, Salah-Eddin Al-Batran, Jörg T Hartmann, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2007
Lectin histochemistry of metastatic adenocarcinomas of the lungIna Thöm, Olaf Schult-Kronefeld, Iris Burkholder, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 27, 2012
Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancerAnna Flammiger, Florian Bayer, Ana Cirugeda-Kühnert, et al.
Blood|February 13, 2008
Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315IArtur Gontarewicz, Stefan Balabanov, Gunhild Keller, et al.
Future Oncology (London, England)|September 9, 2020
Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of care in resectable head and neck squamous cell carcinomaHenrike B Zech, Nikolaus Moeckelmann, Arne Boettcher, et al.
Urologic Oncology|December 25, 2015
Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care--Registry data from an outcomes research project of the German Testicular Cancer Study GroupChristoph Seidel, Karin Oechsle, Anja Lorch, et al.
British Journal of Cancer|September 4, 2015
Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancerAlexander Stein, Djordje Atanackovic, Bert Hildebrandt, et al.
Cancers|April 12, 2022
Indirect Treatment Comparison of Larotrectinib versus Entrectinib in Treating Patients with TRK Gene Fusion CancersJesus Garcia-Foncillas, Carsten Bokemeyer, Antoine Italiano, et al.
Pageof 67